LUTS - Lower Urinary Tract Symptoms is a leading peer-reviewed journal published by Wiley, dedicated to advancing the field of urology and neurology with a special focus on lower urinary tract dysfunctions. Since its inception in 2010, the journal has established itself as an essential resource for researchers and practitioners, featuring cutting-edge research articles, reviews, and clinical studies that explore the complexities of lower urinary tract symptoms and their neurological implications. Housed in Japan, LUTS occupies an important niche in the academic landscape, currently ranked Q2 in Urology and Q3 in Neurology, and holding notable Scopus ranks within both fields. The journal serves as a platform for disseminating innovative ideas and fostering collaborative efforts among experts, making significant contributions to improve patient care and outcomes. With its commitment to high-quality scholarship, LUTS is an indispensable tool for those seeking to stay at the forefront of research in urology and neuroscience.

Actas Urologicas Espanolas is a prestigious journal published by Elsevier España, dedicated to the field of Urology. Established in 1977, this journal has significantly contributed to advancing knowledge and research in urological medicine and surgery, spanning a comprehensive scope that includes clinical studies, surgical techniques, and the latest innovations in the treatment of urological diseases. With an impact factor reflecting its critical role in the academic community, it is ranked Q3 in the Urology category as of 2023, placing it amongst the valuable resources for professionals and researchers. The journal is indexed under Scopus, achieving a commendable rank of #70 out of 120 in the Medicine-Urology category, situating it within the 42nd percentile. As a significant platform for sharing advancements and findings, it encourages submissions that enhance urological care and improve patient outcomes. Although not an Open Access journal, the publication remains vital for those looking to stay updated on the latest developments in urology. For more details, visit their office located at CALLE DE ZURBANO, 76-4TH FLR LEFT, MADRID, 28010, SPAIN.

UROLOGY is a prestigious journal published by Elsevier Science Inc, renowned for disseminating high-quality research and reviews in the field of urology. With an ISSN of 0090-4295 and E-ISSN 1527-9995, this journal has been a trusted resource since its inception in 1973 and continues to provide insights into the latest advancements and clinical practices in urology, maintaining a category quartile of Q2 as of 2023. The journal ranks 50th out of 120 in the Scopus metrics for Medicine - Urology, placing it in the 58th percentile, which underscores its influence and relevance in the academic community. Although it is not structured as an open access journal, it offers a wealth of knowledge vital for researchers, healthcare professionals, and students alike, enabling them to stay abreast of evolving treatments and innovations in the field. As we move towards 2024, UROLOGY remains committed to advancing research and enhancing practices in urological care, fostering a collaborative environment among its readership.

Minerva Obstetrics and Gynecology, an esteemed journal published by EDIZIONI MINERVA MEDICA, serves as a vital resource in the field of obstetrics and gynecology. With an ISSN of 2724-606X and an E-ISSN of 2724-6450, this open access journal aims to disseminate high-quality research and clinical studies that address contemporary challenges and advancements in women's health. Since its inception in 2021, Minerva Obstetrics and Gynecology has garnered recognition within the academic community, achieving a commendable Q3 ranking in the 2023 category of Obstetrics and Gynecology, and placing at the 54th percentile among peers in its Scopus rankings. The journal not only facilitates the exchange of innovative ideas but also encourages collaboration among researchers, healthcare professionals, and students from around the globe. With a commitment to excellence, it aims to address significant topics that impact clinical practice, ensuring that practitioners remain informed about the latest evidence-based practices. For researchers and practitioners aiming to contribute to the advancement of gynecological and obstetric medicine, Minerva Obstetrics and Gynecology represents a prominent platform for publication and engagement.

INTERNATIONAL UROGYNECOLOGY JOURNAL is a premier academic publication dedicated to advancing the field of urogynecology, a vital area of study intersecting urology and obstetrics and gynecology. Published by SPRINGER LONDON LTD in Switzerland, this journal has established its reputation as a critical resource for professionals, researchers, and students alike, contributing significantly to the understanding and management of disorders affecting women's pelvic health. With a commendable Impact Factor reflecting its standing in the academic community, the journal is categorized as Q2 in Obstetrics and Gynecology and Q1 in Urology as of 2023. It ranks within the top 65th percentile in Urology and 63rd percentile in Obstetrics and Gynecology according to Scopus metrics, underscoring its influence and reach within these disciplines. Given its continuous publication since 1990, the INTERNATIONAL UROGYNECOLOGY JOURNAL remains an indispensable platform for disseminating groundbreaking research, clinical studies, and expert reviews essential for improving women's health outcomes worldwide.

Advances in Urology is a premier scholarly journal published by HINDAWI LTD that has been contributing to the field of urology and obstetrics since its establishment. With an impact factor reflecting its growing influence, this Open Access journal, available since 2008, ensures that researchers and professionals can readily access cutting-edge developments in urological health, surgical techniques, and innovative treatment methodologies. Based in the United States, the journal covers a wide array of topics relevant to urology and obstetrics, maintaining a notable presence in academic rankings, with a Q2 category designation in both fields as of 2023. The journal is indexed in Scopus, ranking #54 out of 120 in Urology and #95 out of 209 in Obstetrics and Gynecology, further adding to its credibility and reach. As it converges from 2009 to 2024, Advances in Urology continues to be a vital resource for researchers, professionals, and students seeking to stay abreast of significant advancements and discussions within these critical areas of medicine.

CURRENT OPINION IN UROLOGY is a pivotal journal published by Lippincott Williams & Wilkins, focusing on the latest advancements and critical evaluations in the field of urology. With its ISSN 0963-0643 and E-ISSN 1473-6586, this journal has established a strong presence in the academic community since its inception in 1993. Currently ranked in the top 25 out of 120 journals in the Urology category, it boasts a commendable Q2 quartile ranking in 2023, underscoring its significance and impact within the field. The journal serves as a comprehensive platform for researchers, professionals, and students, aiming to disseminate cutting-edge research, expert reviews, and opinions that shape the practice and studies in urology. While it does not offer open access, subscribers gain valuable insights into the current trends and pivotal discussions that drive the evolution of urological practices and theories. The journal's robust impact factor and esteemed ranking underscore its vital contribution to the scientific discourse in urology.

Urogynecology, published by Lippincott Williams & Wilkins, is a distinguished journal that serves as an essential platform for researchers, clinicians, and students in the fields of obstetrics, gynecology, surgery, and urology. With an impact factor that places it in the Q2 category in various specialties, the journal emphasizes high-quality, peer-reviewed research that contributes to advancements in women's health and pelvic floor disorders. As an Open Access journal, it is committed to enhancing the accessibility of its content, allowing for broader dissemination of knowledge and fostering collaborative efforts in the medical community. Located in India and addressing a global audience, Urogynecology has quickly established its reputation since its inception in 2022, continuing through its converged years until 2024. It is ranked favorably in Scopus across several medical categories, providing a vital resource for cutting-edge research and clinical practice insights. This journal aims to bridge gaps in knowledge and practice, making it an invaluable asset for anyone dedicated to improving outcomes in urogynecology.

Urologic Clinics of North America is a prestigious journal published by W B Saunders Co-Elsevier Inc, dedicated to advancing the field of urology through high-quality, peer-reviewed articles. Since its inception in 1974, this journal has become an essential resource for urologists and researchers, providing insightful clinical reviews, the latest research findings, and practical guidelines for best practices in urological care. With an impressive 2023 category quartile of Q2 in Urology and a commendable Scopus ranking of 34 out of 120 in the Medicine-Urology category, it consistently ranks in the 72nd percentile among its peers. While the journal does not currently offer open access, it remains a critical platform for disseminating significant advancements in the field and fostering professional development. As the journal approaches its 50th year, its enduring commitment to enriching the knowledge base of urology continues to make it a favored publication for both established professionals and students alike.

Bladder Cancer, published by IOS PRESS, is a premier open access journal dedicated to advancing the field of oncology and urology, with a specific focus on bladder cancer research and treatment. Established in 2015 and continuing through to 2024, this journal aims to disseminate high-quality, peer-reviewed research that contributes to the understanding, diagnosis, and management of bladder cancer, a critical area of concern in urological oncology. With a robust publication record now encompassing open access since 2023, Bladder Cancer ensures accessibility to vital research for clinicians, researchers, and scholars worldwide. The journal's rankings in Scopus reflect its commitment to excellence, holding a Q3 category in both oncology and urology, with Scopus ranks of #78 in Urology and #285 in Oncology, showcasing its growing influence in the scientific community. By fostering dialogue and innovation, Bladder Cancer serves as an essential resource for those committed to improving patient outcomes in bladder oncology.